Your account is not claimed yet. You can sign up with ORCID to claim your account.

Olaf Schoffer (O Schoffer)

ResearcherID Scopus Author ID GND ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Vinzenz Völkel, Michael Gerken, Kees Kleihues-van Tol, Olaf Schoffer, Veronika Bierbaum, Christoph Bobeth, Martin Rössle, Christoph Reissfelder, Alois Fürst, Stefan Benz, Bettina M Rau, Pompiliu Piso, Marius Distler, Christian Günster, Judith Hansinger, Jochen Schmitt, Monika Klinkhammer-Schalke
Treatment of Colorectal Cancer in Certified Centers: Results of a Large German Registry Study Focusing on Long-Term Survival. Cancers 15 (18) (2023)
Olaf Schoffer, Dirk Schriefer, Andreas Werblow, Andrea Gottschalk, Peter Peschel, Linda A Liang, Alexander Karmann, Stefanie J Klug
Modelling the effect of demographic change and healthcare infrastructure on the patient structure in German hospitals - a longitudinal national study based on official hospital statistics. BMC health services research 23 (1) (2023)
Linda Ossenbrink, Tina Haase, Patrick Timpel, Olaf Schoffer, Madlen Scheibe, Jochen Schmitt, Stefanie Deckert, Lorenz Harst
Effectiveness of Digital Health Interventions Containing Game Components for the Self-management of Type 2 Diabetes: Systematic Review. JMIR serious games 11 (2023)
Jochen Schmitt, Martin Rössle, Peter Scriba, Felix Walther, Xina Grählert, Maria Eberlein-Gonska, Ralf Kuhlen, Olaf Schoffer
Effect of clinical peer review on mortality in patients ventilated for more than 24 hours: a cluster randomised controlled trial. BMJ quality & safety (2022)
Felix Walther, Jochen Schmitt, Maria Eberlein-Gonska, Ralf Kuhlen, Peter Scriba, Olaf Schoffer, Martin Rössle
Relationships between multiple patient safety outcomes and healthcare and hospital-related risk factors in colorectal resection cases: cross-sectional evidence from a nationwide sample of 232 German hospitals. BMJ open 12 (7) (2022)
Ivana Kern, Olaf Schoffer, Thomas Richter, Wieland Kiess, Gunter Flemming, Ulf Winkler, Jürgen Quietzsch, Olaf Wenzel, Marlen Zurek, Ulf Manuwald, Janice Hegewald, Shi Li, Jens Weidner, Jan de Laffolie, Klaus-Peter Zimmer, Joachim Kugler, Martin W Laass, Ulrike Rothe
Current and projected incidence trends of pediatric-onset inflammatory bowel disease in Germany based on the Saxon Pediatric IBD Registry 2000-2014 -a 15-year evaluation of trends. PloS one 17 (9) (2022)
Ulf Manuwald, Olaf Schoffer, Joachim Kugler, Henna Riemenschneider, Thomas Michael Kapellen, Wieland Kiess, Ulrike Rothe
Trends in incidence and prevalence of type 1 diabetes between 1999 and 2019 based on the Childhood Diabetes Registry of Saxony, Germany. PloS one 16 (12) (2021)
Martin Rössle, Jochen Schmitt, Olaf Schoffer
Can we trust the standardized mortality ratio? A formal analysis and evaluation based on axiomatic requirements. PloS one 16 (9) (2021)
Thomas Datzmann, Olaf Schoffer, F Meier, A Seidler, Jochen Schmitt
Are patients benefiting from participation in the German skin cancer screening programme? A large cohort study based on administrative data. The British journal of dermatology (2021)
Ivana Kern, Olaf Schoffer, Wieland Kiess, Jobst Henker, Martin W Laaß, Ulf Winkler, Jürgen Quietzsch, Olaf Wenzel, Marlen Zurek, Katrin Büttner, Peter Fischer, Jan de Laffolie, Ulf Manuwald, Thoralf Stange, Ronny Zenker, Jens Weidner, Klaus-Peter Zimmer, Hildebrand Kunath, Joachim Kugler, Thomas Richter, Ulrike Rothe
Incidence trends of pediatric onset inflammatory bowel disease in the years 2000-2009 in Saxony, Germany-first results of the Saxon Pediatric IBD Registry. PloS one 16 (1) (2021)
Thomas Datzmann, Jochen Schmitt, Saskia Fuhrmann, Martin Rössle, Friedegund Meier, Olaf Schoffer
Implementation and Effectiveness of Novel Therapeutic Substances for Advanced Malignant Melanoma in Saxony, Germany, 2010-2020-Cohort Study Based on Administrative Data. Cancers 13 (24) (2021)
Peter Hellmund, Jochen Schmitt, Martin Rössle, Friedegund Meier, Olaf Schoffer
Targeted and Checkpoint Inhibitor Therapy of Metastatic Malignant Melanoma in Germany, 2000-2016. Cancers 12 (9) (2020)
Martin Rössle, Jochen Schmitt, Olaf Schoffer
Ranking hospitals when performance and risk factors are correlated: A simulation-based comparison of risk adjustment approaches for binary outcomes. PloS one 14 (12) (2019)

Olaf Schoffer.css-eqlu8i{font-size:small;padding-left:4px;} (O Schoffer)

Publication Activity (10 Years)

Top Topics

Top Venues

Olaf Schoffer (O Schoffer)